Heidelberg Innovation Fonds Management GmbH Company Profile

12:09 EDT 21st September 2018 | BioPortfolio

Heidelberg Innovation invests exclusively in Healthcare companies. Focussing on Medical Devices and Specialty Pharma, the firm is recognized as one of the leading venture capital companies specialized in these sectors. The firm was founded in 1997.With over 50 years of combined experience in the industry, the team currently manages a total of € 125m in three funds.
Heidelberg Innovation employs its in-house know-how in cooperation with a competent, international network to support the successful growth of the portfolio companies.
The thorough selection of investment opportunities in Medical Devices and Specialty Pharma enables Heidelberg Innovation to do successful investments in the most lucrative and strongly growing markets of the Healthcare sector.


Im Neuenheimer Feld 581


Phone: 49-6221 - 64 68 0

News Articles [1141 Associated News Articles listed on BioPortfolio]

DWS übernimmt das Management für einen Fonds von Apple

Wien ( - Prestige-Auftrag für die DWS: Die börsennotierte Fondsgesellschaft übernimmt das Management für einen Fonds des Technologie-Riesen Apple, so die Experten von "FONDS prof...

Ex-Starmanager von J.P. Morgan AM lenkt neuen Jupiter-Income-Fonds

Wien ( - Jupiter Asset Management hat den Jupiter Flexible Income SICAV Fonds lanciert, so die Experten von "FONDS professionell".Der Teilfonds des Jupiter Global Fund SICAV werde...

Heidelberg Pharma: Lizenz- und Forschungsdeal mit Magenta Therapeutics

Heidelberg Pharma hat mit Magenta Therapeutics eine Kooperation im Bereich der Wirkstoffforschung vereinbart. "Heidelberg Pharma Research GmbH unterzeichnete die Vereinbarung, bei der aus Magentas ...

Lloyd Fonds (L1OA) - On the front foot

Edison Investment Research - Financials - Lloyd Fonds: There is a new mood of optimism at Lloyd Fonds. After last year’s missed profit forecasts and strategic disagreement, current ambitious res...

Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement

Heidelberg Pharma AG and Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, announced the si...

Heidelberg Pharma: Anfang 2019 wird es spannend - Exklusiv-Interview

Nach zwei Kapitalerhöhungen ist Heidelberg Pharma bis 2020 durchfinanziert. Im Exklusivinterview mit der Redaktion von erläutert Jan Schmidt-Brand, Vorstandschef von Heidelberg Ph....

GreyOrange clôt une levée de fonds de série C de 140 millions USD, signant la plus grande ...

Ces nouveaux fonds permettront à GreyOrange d'accélérer la réalisation de sa vision consistant à développer la nouvelle génération de systèmes de chaînes logistiques robotiques flexibles Re...

L'université de Tel Aviv crée un fonds de capital-risque

Le fonds exploitera différents programmes d'incubation, aux côtés de partenaires stratégiques, dans divers domaines technologiques. Le premier programme se déroule avec NEC, géant japonais, et...

PubMed Articles [2057 Associated PubMed Articles listed on BioPortfolio]

Relationship between lean practices, soft total quality management and innovation skills in Lebanese hospitals.

Lean practices are critical to eliminate waste and enhance the quality of healthcare services through different improvement approaches of total quality management (TQM). In particular, the soft side o...

Hotspot mutations and ColE1 plasmids contribute to the fitness of Salmonella Heidelberg in poultry litter.

Salmonella enterica subsp. enterica serovar Heidelberg (S. Heidelberg) is a clinically-important serovar linked to food-borne illness, and commonly isolated from poultry. Investigations of a large, mu...

Harnessing Technology Innovation to Improve Patient Care.

Defining Innovation in Neurosurgery: Results from an International Survey.

Innovation is a part of the daily practice of neurosurgery. A clear definition of what constitutes innovation is currently lacking, however, and opinions vary from continent to continent, from hospita...

Innovation contest: Effect of perceived support for learning on participation.

Frontline staff are well positioned to conceive improvement opportunities based on first-hand knowledge of what works and does not work. The innovation contest may be a relevant and useful vehicle to ...

Clinical Trials [2713 Associated Clinical Trials listed on BioPortfolio]

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

Eligible patients underwent evaluation of ocular surface parameters by Ocular Surface Disease Index (OSDI) and Glaucoma Symptom Scale (GSS) questionnaires, Break Up Time test (BUT), Schirm...

How Well Does the Data Obtained From Heidelberg Edge Perimeter Visual Field Compare to Standard Octopus Visual Field

The purpose of this study is to compare standard automated perimetry (SAP) using the Heidelberg Edge Perimeter (HEP) with the Octopus Visual Field (OVF) analyzer and determine test-retest ...

Measuring Cyclotorsion on Scanning Laser Ophthalmoscopy (SLO)-Fundus Photographs

Pre-Study: Evaluation of the inter- and intrarater reliability of the integrated algorithm by Heidelberg Spectralis for measuring cyclotorsion on SLO-fundus fotographs, and assessment of t...

hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of ...

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS

Companies [2754 Associated Companies listed on BioPortfolio]

Heidelberg Innovation Fonds Management GmbH

Heidelberg Innovation invests exclusively in Healthcare companies. Focussing on Medical Devices and Specialty Pharma, the firm is recognized as one of the leading venture capital companies specialized...

Heidelberg Pharma GmbH

When working at Boehringer Mannheim (now Roche Diagnostics) from 1987 to 1999, the founders of Heidelberg Pharma, Dr. Dieter Herrmann and Dr. Hans-Georg Opitz, developed technologies and know-how that...

Technologiepark Heidelberg GmbH

International Science Park with focus on Life Sciences Located close to the University of Heidelberg and to international research institutes [for example: Deutsches Krebsforschungszentrum (DKFZ), E...

Oppenheim Pramerica Fonds Trust GmbH


Gene Bridges GmbH

Gene Bridges GmbH, founded 2000 as a spin-off of the European Molecular Biology Laboratories (EMBL), commercialises the patented Red/ET Recombineering technology. Gene Bridges GmbH Headquarters and ...

More Information about "Heidelberg Innovation Fonds Management GmbH" on BioPortfolio

We have published hundreds of Heidelberg Innovation Fonds Management GmbH news stories on BioPortfolio along with dozens of Heidelberg Innovation Fonds Management GmbH Clinical Trials and PubMed Articles about Heidelberg Innovation Fonds Management GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Heidelberg Innovation Fonds Management GmbH Companies in our database. You can also find out about relevant Heidelberg Innovation Fonds Management GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record